Found 7 matching trials
Immunogenicity and Safety of Meningococcal Vaccine GSK 134612 Co-administered With Pneumococcal and DTPa-HBV-IPV/Hib Vaccines
PHASE3The purpose of this study is to evaluate immunogenicity and safety of menin...
Location
GSK Investigational Site
A Study of the Interaction Between BCG And MenC Immunisation: BAM
PHASE4The Bacille Calmette-Guérin (BCG) vaccine is the only vaccine licenced to p...
Location
University of Oxford, Oxford Vaccine Group
Treatments Being Tested
BCG, NeisVac-C®, Pediacel®, Infanrix™, Prevenar-13®, Menitorix®, Priorix®, Rotarix®BCG, NeisVac-C®, Pediacel®, Infanrix™, Prevenar-13®, Menitorix®, Priorix®, Rotarix®NeisVac-C®, Pediacel®, Infanrix™, Prevenar-13®, Menitorix®, Priorix®, Rotarix® Long-term Persistence Study to Assess a Booster Dose of GSK Biologicals' Hib-MenC
PHASE3This protocol posting deals with objectives \& outcome measures of the exte...
Location
GSK Investigational Site
Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster Dose
PHASE2The current trial will evaluate the safety and immunogenicity of GSK Biolog...
Location
GSK Investigational Site
Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines
PHASE3The purpose of this study is to assess the safety in terms of fever (rectal...
Location
GSK Investigational Site
Pertussis and Meningitis C Concomitant Vaccination in Adolescents
PHASE4The trial includes groups receiving various combinations of meningitis C an...
Location
Gloucestershire primary care
Primary & Booster Study in Infants to Demonstrate Non-inferiority, Persistence & Immunogenicity of Hib-MenC Vaccine
PHASE3The purpose of this primary vaccination phase is to demonstrate the non-inf...
Location
GSK Investigational Site